Prognostic Significance of the Comprehensive Biomarker Analysis in Colorectal Cancer

Պահպանված է:
Մատենագիտական մանրամասներ
Հրատարակված է:Life vol. 15, no. 7 (2025), p. 1100-1132
Հիմնական հեղինակ: Potievskaya Vera
Այլ հեղինակներ: Tyukanova Elizaveta, Sekacheva Marina, Zaki, Fashafsha, Fatyanova Anastasia, Potievskiy Mikhail, Kononova Elena, Kholstinina Anna, Polishchuk Ekatherina, Shegai, Peter, Kaprin Andrey
Հրապարակվել է:
MDPI AG
Խորագրեր:
Առցանց հասանելիություն:Citation/Abstract
Full Text + Graphics
Full Text - PDF
Ցուցիչներ: Ավելացրեք ցուցիչ
Չկան պիտակներ, Եղեք առաջինը, ով նշում է այս գրառումը!

MARC

LEADER 00000nab a2200000uu 4500
001 3233228380
003 UK-CbPIL
022 |a 2075-1729 
024 7 |a 10.3390/life15071100  |2 doi 
035 |a 3233228380 
045 2 |b d20250101  |b d20251231 
084 |a 231529  |2 nlm 
100 1 |a Potievskaya Vera  |u Russian Medical Academy of Postgraduate Education of Federal Scientific and Clinical Center for Specialized Medical Assistance and Medical Technologies of the Federal Medical Biological Agency, Volokolamskoye Shosse, 91, 125371 Moscow, Russia; vera.pot@mail.ru 
245 1 |a Prognostic Significance of the Comprehensive Biomarker Analysis in Colorectal Cancer 
260 |b MDPI AG  |c 2025 
513 |a Journal Article 
520 3 |a Colorectal carcinoma remains one of the primary contributors to cancer deaths; however, it is also considered a preventable type of cancer, because the prognosis of the disease is directly dependent on its timely detection. Developing accurate risk prediction models for colorectal cancer is crucial for identifying individuals at both low and high risk, as risk stratification determines the need for additional interventions, which carry their own risks. The development of new non-invasive diagnostic methods based on biomaterial analysis, alongside standard diagnostic techniques such as colonoscopy with biopsy, computed tomography scanning, and magnetic resonance imaging, can address multiple objectives: improving screening accuracy, providing a comprehensive assessment of minimal residual disease, identifying patients at a high risk of colorectal cancer, and evaluating the effectiveness of ongoing treatments. The lack of sensitive diagnostic methods drives contemporary research toward the discovery of new tools for detecting tumor cells, particularly through the examination of biological materials, including blood, exhaled air, and tumor tissue itself. In this article, we analyze current studies regarding biomarkers in colorectal cancer and prognostic significance. 
653 |a DNA methylation 
653 |a Volatile organic compounds--VOCs 
653 |a Minimal residual disease 
653 |a Accuracy 
653 |a Magnetic resonance imaging 
653 |a Biological materials 
653 |a Biopsy 
653 |a Cancer therapies 
653 |a Mutation 
653 |a Tumors 
653 |a Metabolism 
653 |a Biomaterials 
653 |a Colorectal cancer 
653 |a Risk 
653 |a Prediction models 
653 |a Tumor cells 
653 |a Medical prognosis 
653 |a Surgery 
653 |a Computed tomography 
653 |a Biomedical materials 
653 |a Cancer 
653 |a Biomarkers 
653 |a Colorectal carcinoma 
653 |a Methods 
653 |a Precision medicine 
653 |a Social 
700 1 |a Tyukanova Elizaveta  |u Oncology Department of Antitumor Drug Therapy, Sechenov University Clinical Hospital No.4, I.M. Sechenov First Moscow State Medical University, Str. Dovatora, 15, Bldg. 2, 119048 Moscow, Russia; fatyanova_e_s@staff.sechenov.ru (A.F.); kholstinina.anna@mail.ru (A.K.); sagekthadley@gmail.com (E.P.) 
700 1 |a Sekacheva Marina  |u World-Class Reserch Centre «Digital Biodesign and Personalized Healthcare», I.M. Sechenov First Moscow State Medical University (Sechenov University), Str. Bolshaya Pirogovskaya, 6, Bldg. 1, 119991 Moscow, Russia; sekacheva_m_i@staff.sechenov.ru 
700 1 |a Zaki, Fashafsha  |u P. Hertsen Moscow Oncology Research Institute—Branch or the Federal State Budgetary Institution “National Medical Research Radiological Centre” of the Ministry of Health of the Russian Federation, 2nd Botkinsky Proezd, 3, 125284 Moscow, Russia; elena24936@yandex.ru 
700 1 |a Fatyanova Anastasia  |u Oncology Department of Antitumor Drug Therapy, Sechenov University Clinical Hospital No.4, I.M. Sechenov First Moscow State Medical University, Str. Dovatora, 15, Bldg. 2, 119048 Moscow, Russia; fatyanova_e_s@staff.sechenov.ru (A.F.); kholstinina.anna@mail.ru (A.K.); sagekthadley@gmail.com (E.P.) 
700 1 |a Potievskiy Mikhail  |u Federal State Budgetary Institution “National Medical Research Radiological Centre” of the Ministry of Health of the Russian Federation, 4, Koroleva Street, 249036 Obninsk, Russia; potievskiymikhail@gmail.com (M.P.); dr.shegai@mail.ru (P.S.); kaprin@mail.ru (A.K.) 
700 1 |a Kononova Elena  |u P. Hertsen Moscow Oncology Research Institute—Branch or the Federal State Budgetary Institution “National Medical Research Radiological Centre” of the Ministry of Health of the Russian Federation, 2nd Botkinsky Proezd, 3, 125284 Moscow, Russia; elena24936@yandex.ru 
700 1 |a Kholstinina Anna  |u Oncology Department of Antitumor Drug Therapy, Sechenov University Clinical Hospital No.4, I.M. Sechenov First Moscow State Medical University, Str. Dovatora, 15, Bldg. 2, 119048 Moscow, Russia; fatyanova_e_s@staff.sechenov.ru (A.F.); kholstinina.anna@mail.ru (A.K.); sagekthadley@gmail.com (E.P.) 
700 1 |a Polishchuk Ekatherina  |u Oncology Department of Antitumor Drug Therapy, Sechenov University Clinical Hospital No.4, I.M. Sechenov First Moscow State Medical University, Str. Dovatora, 15, Bldg. 2, 119048 Moscow, Russia; fatyanova_e_s@staff.sechenov.ru (A.F.); kholstinina.anna@mail.ru (A.K.); sagekthadley@gmail.com (E.P.) 
700 1 |a Shegai, Peter  |u Federal State Budgetary Institution “National Medical Research Radiological Centre” of the Ministry of Health of the Russian Federation, 4, Koroleva Street, 249036 Obninsk, Russia; potievskiymikhail@gmail.com (M.P.); dr.shegai@mail.ru (P.S.); kaprin@mail.ru (A.K.) 
700 1 |a Kaprin Andrey  |u Federal State Budgetary Institution “National Medical Research Radiological Centre” of the Ministry of Health of the Russian Federation, 4, Koroleva Street, 249036 Obninsk, Russia; potievskiymikhail@gmail.com (M.P.); dr.shegai@mail.ru (P.S.); kaprin@mail.ru (A.K.) 
773 0 |t Life  |g vol. 15, no. 7 (2025), p. 1100-1132 
786 0 |d ProQuest  |t Biological Science Database 
856 4 1 |3 Citation/Abstract  |u https://www.proquest.com/docview/3233228380/abstract/embedded/L8HZQI7Z43R0LA5T?source=fedsrch 
856 4 0 |3 Full Text + Graphics  |u https://www.proquest.com/docview/3233228380/fulltextwithgraphics/embedded/L8HZQI7Z43R0LA5T?source=fedsrch 
856 4 0 |3 Full Text - PDF  |u https://www.proquest.com/docview/3233228380/fulltextPDF/embedded/L8HZQI7Z43R0LA5T?source=fedsrch